FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES Stock

Certificat

DE000SB0QMV3

Delayed Deutsche Boerse AG 02:53:18 2024-05-24 EDT
4.92 EUR -0.40% Intraday chart for FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES
Current month-4.63%
1 month+1.86%
Date Price Change
24-05-24 4.92 -0.40%
24-05-23 4.94 +3.56%
24-05-22 4.77 +0.21%
24-05-21 4.76 +1.93%
24-05-20 4.67 -1.27%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 02:53 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SB0QMV
ISINDE000SB0QMV3
Date issued 2020-06-04
Strike 73.21 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.98
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 12.58
Lowest since issue 2.93
Spread 0.04
Spread %0.81%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
66.17 USD
Average target price
82.77 USD
Spread / Average Target
+25.09%
Consensus